Columbia Wanger Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Columbia Wanger Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$6.86M	Buy	117,425 +16,108	+16%	+$1.02M	0.1%	205
2017 Q3	$5.88M	Buy	101,317 +27,507	+37%	+$2.96M	0.09%	198
2017 Q2	$8.94M	Buy	+73,810	New	+$8.55M	0.13%	186
2016 Q4	–	Sell	-192,510	Closed	-$31.7M	–	201
2016 Q3	$31.7M	Sell	192,510 -41,063	-18%	-$6.47M	0.42%	110
2016 Q2	$33.3M	Buy	233,573 +46,530	+25%	+$6.78M	0.39%	119
2016 Q1	$24M	Buy	187,043 +171	+0.1%	+$20.2K	0.26%	128
2015 Q4	$27.9M	Sell	186,872 -22,946	-11%	-$3.88M	0.28%	129
2015 Q3	$34.8M	Sell	209,818 -65,861	-24%	-$14.5M	0.28%	137
2015 Q2	$66.5M	Sell	275,679 -40,171	-13%	-$10.7M	0.43%	88
2015 Q1	$89.1M	Sell	315,850 -78,000	-20%	-$16.9M	0.48%	77
2014 Q4	$61.4M	Buy	393,850 +210,550	+115%	+$38.9M	0.3%	107
2014 Q3	$43.4M	Hold	183,300	–	–	0.2%	167
2014 Q2	$43.4M	Buy	183,300 +50,300	+38%	+$13.3M	0.17%	190
2014 Q1	$43.9M	Buy	+133,000	New	+$44.9M	0.17%	191

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Columbia Wanger Asset Management's ICPT Position: Q4 2017 in Review

Columbia Wanger Asset Management increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 16% in Q4 2017, buying an estimated $1.02M and bringing the position to 117,425 shares worth $6.86M. The position accounts for 0.1% of the portfolio, ranked #205.

Columbia Wanger Asset Management first reported a position in ICPT in Q1 2014 and has held it in 14 quarters since. The position peaked at $89.1M in Q1 2015. 168 funds tracked by Wall St. Rank hold ICPT as of Q4 2017.

Columbia Wanger Asset Management held 117,425 shares of Intercept Pharmaceuticals, Inc. worth $6.86M as of Q4 2017.
Columbia Wanger Asset Management bought 16,108 Intercept Pharmaceuticals, Inc. shares in Q4 2017, an estimated $1.02M.
Intercept Pharmaceuticals, Inc. made up 0.1% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #205 holding.
Columbia Wanger Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and has held it in 14 quarters since.
Columbia Wanger Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $89.1M in Q1 2015.
168 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.